Co-Founder and CEO
Meet Medable Studio - Book Your 1:1 Consultation
Introducing Medable Studio: an enterprise-grade interface designed for effortless self-service and full-service study design, editing, and launch.
More than an eCOA builder, Medable Studio brings total control and transparency to the study launch process with a simple point and click interface.
See how Studio can help you:
• Take control of your eCOA process and eliminate roadblocks of traditional build processes
• Collect better data and reduce the risk of error in every step
• Minimize time, cost, and impact of protocol changes throughout the build process
Book a 1:1 consultation by filling out the form, then selecting your time on the following page!
Book a meeting
Schedule a meeting or demo with our platform experts at our DIA booth.
Book your consultation
You'll be directed to a page to select a time
Meet the Medable team
Come by booth # to talk with one of our clinical research and trial experts.
Chief Scientific Officer
Pamela Tenaerts
Discuss recent and current research on DCTs and current state of novel clinical trial methodologies.
Chief Revenue Officer
Jason Rothbart
Discuss your DCT and enterprise solutions for pharma and biotech.
VP, GM, eConsent
Andrew Mackinnon
Discuss on eConsent, Site adoption AI, and the latest Duke University Base Lab pilot study results.
Senior Vice President, Sales
Martin Cook
Discuss your DCT and enterprise solutions for pharma and biotech.
VP ECOA
Cindy Howry
Discuss eCOA strategy, current FDA Guidelines, and how to best plan for using eCOA in your trial
VP ADOPTION & CHANGE MANAGEMENT
Camila Matheny
Discuss effective strategies to implement digital trials for your studies.
SVP of Global Enterprise Sales
Dave Orrico
Discuss your DCT and enterprise solutions for pharma and biotech.
Solution Consultant
Rj Lozano
Meet to receive a product demo for Total Consent, eCOA+ and more.
Intersection of Innovative Development Models and Investment Approaches That Move the Needle at the Portfolio Level
New to SCOPE 2024 - we bring together for the first time, a business-focused panel of strategics from the pharma, investor, healthcare, CRO, and technology start-up communities, to discuss partnership models that drive much needed innovation in clinical trials and impact development at the portfolio level. In this panel we will address the following questions:
- How can Pharma manage risks and investments while continuing to remain at the forefront of drug development, clinical research, and trial technology?
- What alternative business models and risk-sharing partnership can support innovation, in a resource constrained environment?
- Where are the opportunities and the ROI from such partnerships?
- What emerging technologies are showing growth and investment and are moving the needle in clinical research?
TBD
Tuesday, February 13
3:30 PM EST
30 minutes
FEB
13
The New Frontier:
How Intelligent Automation is Transforming Clinical Deployment
Join us as Colin Weller, GM, Evidence Generation Platform at Medable, unveils how intelligent automation technology reduces clinical trial deployment timelines and accelerates evidence generation at scale as shown in their latest results to reduce trial deployment timelines by 50%. Weller will discuss how Top-10 global pharmaceutical companies are benefiting from Medable’s novel technology, and how the expanded use of digital measures and biomarkers will continue to accelerate clinical development timelines.
- TBD
- Tuesday, February 13
- 8:30 AM EST
- 30 minutes
FEB
13
SESSION HIGHLIGHT
Responsibility and Oversight in Decentralized Clinical Trials
Join Medable’s CSO, Pamela Tenaerts to discuss issues that drive principal investigator (PI) oversight and responsibility in modern clinical trials where research and data gathering activities are no longer confined to the traditional site model.
Wed, June 28 | 10:30-11:30am
Wed, June 28 | 10:30-11:30am
ROUNDTABLE DISCUSSION
RWD: Maximizing Value and Quality through End-to-End Patient Centricity
Join Medable’s VP, Digital Transformation Strategy, Reem Yunis and Walgreen’s Head, Digital Optimization, RWE Clinical Trials, Kendal Whitlock for a follow up roundtable discussion tied to session: Real-World Data: Maximizing Value and Quality through End-to-End Patient Centricity.
Wed, June 28 | 1:15-2:15pm
Wed, June 28 | 1:15-2:15pm
You’re on the list.
Somebody will reach out to you soon to schedule a sneak peek of our upcoming product features and capabilities. In the meantime, enjoy our latest content about the future of clinical trials.
